Ten years’ disease-free survival of advanced epithelial ovarian cancer treated by cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy-Reference-Cited by-同舟云学术

Ten years’ disease-free survival of advanced epithelial ovarian cancer treated by cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy

Published:2020-12-04 Issue:49 Volume:99 Page:e23404
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Zhang Jue,Mei Liejun,Wang Fubing,Li Yan

Funder

Hubei Provincial Natural Science Foundation of China

Beijing Municipal Administration of Hospitals’ Ascent Plan

Special Fund for the Capital Characteristic Clinical Medicine Development Project

Beijing Natural Science Foundation

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference19 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017

2. Ovarian cancer;Hennessy;Lancet,2009

3. G Gynecologic Oncology. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study;Ozols;J Clin Oncol,2003

4. Looking up: recent advances in understanding and treating peritoneal carcinomatosis;Lambert;CA Cancer J Clin,2015

5. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer: a phase II clinical study;Deraco;Tumori,2001

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and feasibility of hyperthermic intraperitoneal chemotherapy during interval cytoreductive surgery in patients with advanced high‐grade serous ovarian, fallopian tube, peritoneal cancer in an Australian context;Australian and New Zealand Journal of Obstetrics and Gynaecology;2023-05-31